IBDEI08C ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3344,1,4,0)
 ;;=4^R63.3
 ;;^UTILITY(U,$J,358.3,3344,2)
 ;;=^5019541
 ;;^UTILITY(U,$J,358.3,3345,0)
 ;;=E87.8^^28^252^35
 ;;^UTILITY(U,$J,358.3,3345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3345,1,3,0)
 ;;=3^Fluid & Electrolyte Balance Disorder NEC
 ;;^UTILITY(U,$J,358.3,3345,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,3345,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,3346,0)
 ;;=E87.70^^28^252^36
 ;;^UTILITY(U,$J,358.3,3346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3346,1,3,0)
 ;;=3^Fluid Overload,Unspec
 ;;^UTILITY(U,$J,358.3,3346,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,3346,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,3347,0)
 ;;=R73.01^^28^252^50
 ;;^UTILITY(U,$J,358.3,3347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3347,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,3347,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,3347,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,3348,0)
 ;;=R73.02^^28^252^51
 ;;^UTILITY(U,$J,358.3,3348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3348,1,3,0)
 ;;=3^Impaired Oral Glucose Tolerance
 ;;^UTILITY(U,$J,358.3,3348,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,3348,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,3349,0)
 ;;=E83.119^^28^252^37
 ;;^UTILITY(U,$J,358.3,3349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3349,1,3,0)
 ;;=3^Hemochromatosis,Unspec
 ;;^UTILITY(U,$J,358.3,3349,1,4,0)
 ;;=4^E83.119
 ;;^UTILITY(U,$J,358.3,3349,2)
 ;;=^5002995
 ;;^UTILITY(U,$J,358.3,3350,0)
 ;;=E83.52^^28^252^38
 ;;^UTILITY(U,$J,358.3,3350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3350,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,3350,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,3350,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,3351,0)
 ;;=E11.65^^28^252^22
 ;;^UTILITY(U,$J,358.3,3351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3351,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,3351,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,3351,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,3352,0)
 ;;=R73.9^^28^252^39
 ;;^UTILITY(U,$J,358.3,3352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3352,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,3352,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,3352,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,3353,0)
 ;;=E87.5^^28^252^41
 ;;^UTILITY(U,$J,358.3,3353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3353,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,3353,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,3353,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,3354,0)
 ;;=E83.41^^28^252^42
 ;;^UTILITY(U,$J,358.3,3354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3354,1,3,0)
 ;;=3^Hypermagnesemia
 ;;^UTILITY(U,$J,358.3,3354,1,4,0)
 ;;=4^E83.41
 ;;^UTILITY(U,$J,358.3,3354,2)
 ;;=^5003002
 ;;^UTILITY(U,$J,358.3,3355,0)
 ;;=E87.0^^28^252^43
 ;;^UTILITY(U,$J,358.3,3355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3355,1,3,0)
 ;;=3^Hyperosmolality/Hypernatremia
 ;;^UTILITY(U,$J,358.3,3355,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,3355,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,3356,0)
 ;;=E83.51^^28^252^45
 ;;^UTILITY(U,$J,358.3,3356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3356,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,3356,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,3356,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,3357,0)
 ;;=E58.^^28^252^3
 ;;^UTILITY(U,$J,358.3,3357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3357,1,3,0)
 ;;=3^Calcium Deficiency,Dietary
 ;;^UTILITY(U,$J,358.3,3357,1,4,0)
 ;;=4^E58.
 ;;^UTILITY(U,$J,358.3,3357,2)
 ;;=^5002804
 ;;^UTILITY(U,$J,358.3,3358,0)
 ;;=E11.641^^28^252^23
 ;;^UTILITY(U,$J,358.3,3358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3358,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hypoglycemia w/ Coma
